1. CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib. (3rd July 2019) Authors: Castillo, Jorge J.; Xu, Lian; Gustine, Joshua N.; Keezer, Andrew; Meid, Kirsten; Dubeau, Toni E.; Liu, Xia; Demos, Maria G.; Kofides, Amanda; Tsakmaklis, Nicholas; Chen, Jiaji G.; Munshi, Manit; Guerrera, Maria L.; Chan, Gloria G.; Patterson, Christopher J.; Yang, Guang; Hunter, Zachary R.; Treon... Journal: British journal of haematology Issue: Volume 187:Number 3(2019) Page Start: 356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Deepening of response after completing rituximab‐containing therapy in patients with Waldenstrom macroglobulinemia. Issue 4 (7th January 2020) Authors: Castillo, Jorge J.; Gustine, Joshua N.; Keezer, Andrew; Meid, Kirsten; Flynn, Catherine A.; Dubeau, Toni E.; Chan, Gloria; Chen, Jiaji; Demos, Maria G.; Guerrera, Maria L.; Jimenez, Cristina; Kofides, Amanda; Liu, Xia; Munshi, Manit; Tsakmaklis, Nicholas; Patterson, Christopher J.; Xu, Lian; Yang... Journal: American journal of hematology Issue: Volume 95:Issue 4(2020:Apr.) Page Start: 372 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗